The variant C levels were elevated in the CSF of patients with ALS (Fig. 2, C and D), suggesting that the increased variant C levels of RGMa play a pivotal role in activating the NEO1 signaling pathway in the central nervous system (CNS) of patients with ALS. The gene discussed is RGMA; the disease is amyotrophic lateral sclerosis.